TITLE

Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease

AUTHOR(S)
Craig, D; Hart, D J; McCool, K; Mcilroy, S P; Passmore, A P
PUB. DATE
September 2004
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Sep2004, Vol. 75 Issue 9, p1327
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
The rising number of people with cognitive impairment is placing health care budgets under significant strain. Dementia related behavioural change is a major independent risk factor for admission to expensive institutional care, and aggressive symptoms in particular are poorly tolerated by carers and frequently precipitate the collapse of home coping strategies. Aggressive change may result from known genetic risk factors for Alzheimer's disease (AD) and therefore accompany conventional markers such as apolipoprotein E (ApoE). We tested this hypothesis in 400 moderately to severely affected AD patients who were phenotyped for the presence of aggressive or agitated behaviour during the month prior to interview using the Neuropsychiatric Inventory with Caregiver Distress. The proportion of subjects with aggression/agitation in the month prior to interview was 51.8%. A significantly higher frequency of the e4 allele was found in individuals recording aggression/agitation in the month prior to interview (chi2 = 6.69, df = 2, p = 0.03). The additional risk for aggression/agitation conferred by e4 was also noted when e4 genotypes were compared against non-e4 genotypes (chi2 = 5.45, df = 1, p = 0.02, OR = 1.60, confidence interval (CI) 1.06 to 2.43). These results indicate that advanced Alzheimer's disease patients are at greater risk of aggressive symptoms because of a genetic weakness in apolipoprotein E.
ACCESSION #
14433346

 

Related Articles

  • A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease. Herrmann, Nathan; Lanctôt, Krista L.; Rothenburg, Lana S.; Eryavec, Goran // Dementia & Geriatric Cognitive Disorders;2007, Vol. 23 Issue 2, p116 

    Background/Aims: To assess the efficacy and tolerability of valproate for the treatment of agitation and aggression in moderate-to-severe Alzheimer’s disease (AD). Methods: This was a randomized, double-blind, placebo-controlled crossover trial of valproate in institutionalized AD...

  • Neuronal LR11 Expression Does Not Differentiate between Clinically-Defined Alzheimer's Disease and Control Brains. Sager, Kristen L.; Wuu, Joanne; Herskowitz, Jeremy H.; Mufson, Elliott J.; Levey, Allan I.; Lah, James J.; Ginsberg, Stephen D. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Alzheimer's disease (AD) is the leading cause of dementia in the elderly. Because the pathological changes underlying this disease can begin decades prior to the onset of cognitive impairment, identifying the earliest events in the AD pathological cascade has critical implications for both...

  • A Naturalistic Study of Galantamine for Alzheimer’s Disease. Brodaty, Henry; Woodward, Michael; Boundy, Karyn; Barnes, Nicola; Allen, Gabrielle // CNS Drugs;2006, Vol. 20 Issue 11, p935 

    OBJECTIVE: To collect descriptive data on the treatment of Alzheimer’s disease with galantamine under naturalistic conditions.At 6 months, most PP subjects (70%) showed an increase in MMSE score compared with baseline, with a mean increase in score of 2.0 ± 3.1 points from a baseline...

  • Neurobiology and Genetics of Behavioural Syndromes of Alzheimer's Disease. McIlroy, Stephen; Craig, David // Current Alzheimer Research;Apr2004, Vol. 1 Issue 2, p135 

    The number of people with cognitive impairment is rising in parallel with changing demographics. As health care budgets are coming under increasing strain with regard to the provision of nursing care, there is a substantial need for effective therapies which encompass greater understanding of...

  • The Role of Functional Neuroimaging in Mild Cognitive Impairment. Marcos, Alberto; Barabash, Ana; Gil, Pedro; Encinas, Marta; De Juan, Ramón; Payno, María; Ancín, Inés; Vázquez, Blanca; Antonio Cabranes, José // Current Medical Imaging Reviews;2006, Vol. 2 Issue 2, p237 

    Mild Cognitive impairment (MCI) is a frequent problem in the elderly, since many of MCI subjects progress into Alzheimer's disease (AD). Recently new treatment options have been developed that may alter or delay the rate of AD deterioration. Wherefore, detecting and recognising patients that...

  • Dementia in Swedish Twins: Predicting Incident Cases. Gatz, Margaret; Reynolds, Chandra A.; Finkel, Deborah; Pedersen, Nancy L.; Walters, Ellen // Behavior Genetics;Nov2010, Vol. 40 Issue 6, p768 

    Thirty same-sex twin pairs were identified in which both members were assessed at baseline and one twin subsequently developed dementia, at least 3 years subsequent to the baseline measurement, while the partner remained cognitively intact for at least three additional years. Eighteen of the 30...

  • RESEARCH ROUNDUP. Harrison-Dening, Karen // British Journal of Neuroscience Nursing;Aug2012, Vol. 8 Issue 4, p204 

    The article summarizes new research of interest to neuroscience nurses: a review paper evaluates evidence suggesting that some antihypertensive drugs reduce the risk and progression of Alzheimer's disease more than others; a study uses the Mini Mental State Examination to determine the...

  • Atrophy: When too much atrophy is too little brain. Romanowski, Charles; Wilkinson, Iain // Neuroradiology;Sep2011, Vol. 53, p133 

    The article discusses brain atrophy in the contexts of normal ageing and Alzheimer's disease (AD). The prevalence of AD and its possible connection with mild cognitive impairment (MCI) is mentioned. The discussion focuses on subtle changes that differentiate patients undergoing the normal...

  • Incidence of dementia and cognitive decline in over-75s in Cambridge: overview of cohort study. Paykel, E. S.; Huppert, F. A.; Brayne, C. // Social Psychiatry & Psychiatric Epidemiology;1998, Vol. 33 Issue 8, p387 

    This paper summarises the methods and some of the findings of a large cohort study of dementia and cognitive decline in subjects aged over 75 years in Cambridge, particularly regarding the incidence wave. From a sample of 1968 subjects previously studied in a prevalence study in 1985-1987,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics